andrew huberman retatrutide The Last - clarifies he is not taking GLP-1s despite discussing the trend of celebrities using for weight management. >> πLinkπ Researcher Spotlight: Andrew Huberman, PhD
Description
Abstract Metformin or glucagon-like peptide-1 (GLP-1) analogue liraglutide has cardiovascular benefits
PMID: 37296162
Lead author Professor Sunil Badve, Professorial Fellow at The George Institute for Global Health and UNSW Sydney said the study expanded current knowledge about this class of drugs in key areas, including benefits in people with CKD, and in people with and without diabetes
Metabolic Function Your body's metabolic processes including fat burning occur during sleep, making quality rest essential for optimal results
Shiraishi et al
Zhong, W
